- Home
- MRVI vs MNTK Comparison
MRVI vs MNTK Comparison
Compare MRVI & MNTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- MNTK
- Stock Information
- Founded
- MRVI 2014
- MNTK 1980
- Country
- MRVI United States
- MNTK United States
- Employees
- MRVI N/A
- MNTK N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- MNTK Natural Gas Distribution
- Sector
- MRVI Health Care
- MNTK Utilities
- Exchange
- MRVI Nasdaq
- MNTK Nasdaq
- Market Cap
- MRVI 371.8M
- MNTK 306.2M
- IPO Year
- MRVI 2020
- MNTK 2021
- Fundamental
- Price
- MRVI $2.42
- MNTK $2.15
- Analyst Decision
- MRVI Hold
- MNTK Hold
- Analyst Count
- MRVI 10
- MNTK 3
- Target Price
- MRVI $5.84
- MNTK $3.33
- AVG Volume (30 Days)
- MRVI 1.5M
- MNTK 223.8K
- Earning Date
- MRVI 08-11-2025
- MNTK 08-06-2025
- Dividend Yield
- MRVI N/A
- MNTK N/A
- EPS Growth
- MRVI N/A
- MNTK N/A
- EPS
- MRVI N/A
- MNTK 0.02
- Revenue
- MRVI $219,830,000.00
- MNTK $181,341,000.00
- Revenue This Year
- MRVI N/A
- MNTK $3.74
- Revenue Next Year
- MRVI $7.23
- MNTK $3.88
- P/E Ratio
- MRVI N/A
- MNTK $116.00
- Revenue Growth
- MRVI N/A
- MNTK N/A
- 52 Week Low
- MRVI $1.67
- MNTK $1.68
- 52 Week High
- MRVI $9.60
- MNTK $6.04
- Technical
- Relative Strength Index (RSI)
- MRVI 49.60
- MNTK 51.51
- Support Level
- MRVI $2.28
- MNTK $1.98
- Resistance Level
- MRVI $2.47
- MNTK $2.26
- Average True Range (ATR)
- MRVI 0.14
- MNTK 0.10
- MACD
- MRVI -0.01
- MNTK 0.03
- Stochastic Oscillator
- MRVI 27.45
- MNTK 72.50
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About MNTK Montauk Renewables Inc.
Montauk Renewables Inc is a renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments namely Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.